Top compounds associated with response to CCDC124


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00091 1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00096 1
mRNA Crizotinib GDSC1000 pan-cancer AAC -0.0014 1
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.00087 1
mRNA R428 CTRPv2 pan-cancer AAC 0.0011 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00075 1
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.0012 1
mRNA masitinib GDSC1000 pan-cancer AAC -0.00065 1
mRNA foretinib CTRPv2 pan-cancer AAC 0.00071 1
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.00072 1
Download CSV